FOII® –
2nd generation Oligo Fucoidan
Compact size
Enhanced and increase contact surface area
Additional 40% improvement in regulating physiological functions
ABOUT US
Translab International Ltd., is leading by General Manager Huang Mingxin and Deputy General Manager Yang Zhonghan, a pioneer innovative biotechnology company in Taiwan. Our R&D team collaborates with top medical universities & research institutions, specializing in “translational medicine” and developing the patented technology FOII® 2nd generation Oligo Fucoidan . Our research development is published in leading scientific journals, with clinical trials showing exceptional results.
Join collaboration with Material World Industrial Co.Ltd., a 25 years company in importing and exporting health & cosmetics ingredients.
Innovative product development in patented technology FOII 2nd generation Oligo Fucoidan.
International recognized health ingredients and supplements products.
GMP, ISO22000, HACPP standard manufacturing facilities Collaboration with top researchers and universities.
Company Services and Global Business Developmement
Distributor Services
Translab Brand Supplements
Distributor Services
Health Ingredients Supplies
ODM/OEM Services
Health Supplements
Latest News
Company leading advantages
Multiple countries & national patents
Proven Human Clinical Trial
3 times more bioactive than 1st generation
99% high concentration water soluble oligo fucoidan